Successful Early Rescue with Isatuximab Plus Carfilzomib-Dexamethasone (ISA-KD) in Daratumumab-Refractory Newly Diagnosed Multiple Myeloma (NDMM) Patients with “No Washout Period”: A Real-World Clinical Experience in A Case Series and Literature Review. (2026). Archives of Clinical and Medical Case Reports, 10(1), 1-5. https://fortunejournals.org/ojs/index.php/acmcr/article/view/23020